D-2L, D-2S, and D-3 dopamine receptors stably transfected into NG108-15 cells couple to a voltage-dependent potassium current via distinct G protein mechanisms

被引:0
作者
Liu, LX
Monsma, FJ
Sibley, DR
Chiodo, LA
机构
[1] TEXAS TECH UNIV, HLTH SCI CTR, DEPT PHARMACOL, SCH MED, LUBBOCK, TX 79430 USA
[2] NINCDS, MOL NEUROPHARMACOL SECT, EXPT THERAPEUT BRANCH, NIH, BETHESDA, MD 20892 USA
关键词
transfection; DA receptors; D-2 receptor isoforms; D-2; receptors; G(O alpha); G(S alpha); G proteins; whole-cell patch clamp; signal transduction;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The D-2-like dopamine (DA) receptor family has continued to expand and now includes the D-2-short (D-2S) and DB-long (D-2L) receptor isoforms and the D-3 and D-4 receptors. The D-2 receptor isoforms differ in length by 29 amino acids within the third cytoplasmic loop, a region of the receptor believed to be important for G protein coupling. This observation has led to the hypothesis that the two isoforms of the D-2 receptor may utilize different signal transduction pathways when present in the same cell. The D-2 and D-3 receptors, although mostly different, show some common amino acid sequences within the third cytoplasmic loop. Thus, it is possible that the D-2 and D-3 receptors may employ similar signal transduction pathways. To test these hypotheses directly, NG108-15 neuroblastoma-glioma hybrid cells were stably transfected to express either the Das, D-2L, Or D-3 DA receptors. All transfected but not untransfected NG108-15 cells demonstrated a dose-dependent reduction in the peak whole-cell potassium (K+) current in response to receptor activation by DA or the DA receptor agonists quinpirole (QUIN) and apomorphine (APO). The modulation of K+ current by D-2S receptor stimulation was prevented by pretreatment of the cells with cholera toxin (20 mu g/ml for 18 h), whereas pertussis toxin pretreatment (500 ng/ml for 4 h) completely blocked the effects of D-2L and D-3 receptor activation. These observations suggest that the signal transduction mechanisms involved in coupling the two isoforms of the D-2 receptor to the K+ current are different, whereas the D-2L and D-3 receptor coupling mechanisms may be similar. In direct support of this hypothesis, it was observed that the intracellular application of a polyclonal antibody that is specific for the G(O alpha) subunit completely blocked the ability of D-2L and D-3 receptors to modulate outward K+ currents. In contrast, the D-2S-mediated modulation of K+ currents was blocked by intracellular application of an antibody recognizing G(S alpha) but not G(O alpha). These findings demonstrate that D-2S and D-2L receptors are able to couple to a common effector in a cell via two G protein pathways. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:156 / 164
页数:9
相关论文
共 35 条
[1]   DIRECT G-PROTEIN GATING OF ION CHANNELS [J].
BROWN, AM ;
BIRNBAUMER, L .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (03) :H401-H410
[2]   CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA [J].
BUNZOW, JR ;
VANTOL, HHM ;
GRANDY, DK ;
ALBERT, P ;
SALON, J ;
CHRISTIE, MJ ;
MACHIDA, CA ;
NEVE, KA ;
CIVELLI, O .
NATURE, 1988, 336 (6201) :783-787
[3]  
CASTELLANO MA, 1993, MOL PHARMACOL, V44, P649
[4]   COUPLING OF D2 DOPAMINE-RECEPTORS AND D3 DOPAMINE-RECEPTORS TO G-PROTEINS [J].
CASTRO, SW ;
STRANGE, PG .
FEBS LETTERS, 1993, 315 (03) :223-226
[5]  
CHIO CL, 1994, J BIOL CHEM, V269, P11813
[6]  
CHIODO LA, 1992, NEUROCHEM INT, V20, pS81
[7]  
Chiodo Louis A., 1995, P221
[8]   THE DOPAMINE-D2 RECEPTOR - 2 MOLECULAR-FORMS GENERATED BY ALTERNATIVE SPLICING [J].
DALTOSO, R ;
SOMMER, B ;
EWERT, M ;
HERB, A ;
PRITCHETT, DB ;
BACH, A ;
SHIVERS, BD ;
SEEBURG, PH .
EMBO JOURNAL, 1989, 8 (13) :4025-4034
[9]   GUANINE NUCLEOTIDE-BINDING PROTEIN GO-INDUCED COUPLING OF NEUROPEPTIDE Y-RECEPTORS TO CA-2+ CHANNELS IN SENSORY NEURONS [J].
EWALD, DA ;
STERNWEIS, PC ;
MILLER, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3633-3637
[10]   [H-3] 7-OH-DPAT IS CAPABLE OF LABELING DOPAMINE D-2 AS WELL AS D-3 RECEPTORS [J].
GONZALEZ, AM ;
SIBLEY, DR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 272 (01) :R1-R3